Pfizer/Biontech Says Three Doses ‘Effective’ Against Omicron
Luis ROBAYO / AFP
The coronavirus vaccine developed jointly by BioNTech and Pfizer is “still effective” against the Omicron variant of the virus after three doses, the German company said in a statement on Wednesday.
An Omicron-specific version of the jab, currently in development by BioNTech, would be available “by March”, it added.
![[Video] Woman Cries Out As Soldier Ants Invade Her House](https://i0.wp.com/www.brainnewspaper.com/wp-content/uploads/2024/02/Woman-Cries-Out-As-Soldier-Ants-Invade-Her-House.jpg?resize=720%2C450&ssl=1)
![[Photo] What Is The Importance Of This Hole?](https://i0.wp.com/www.brainnewspaper.com/wp-content/uploads/2023/07/What-Is-The-Importance-Of-This-Hole.jpg?resize=332%2C415&ssl=1)
